Function of Appican and Sulfation Pattern in AD Brains
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000024
Summary
The amyloid precursor protein (APP) is produced in different forms (called isoforms), and one of these isoforms has been found by Dr. Shioi to be the core protein of a complex type of protein called a chondroitin sulfate proteoglycan (a protein that contains sulfur and sugar molecules). Dr. Shioi calls this APP-containing protein “appican.” Appican is found in brain tissue and is produced by a type of brain cell (called an astrocyte) in cell culture, but non-neuronal cell lines produce little or no appican. Recent evidence suggests that chondroitin sulfate proteoglycans are involved in neuronal growth and development. Dr. Shioi is examining the possible role of appican in normal brain function and whether this role is changed in Alzheimer’s disease (AD). The results of these experiments could identify a new role for the APP protein in AD.
Related Grants
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University